Latest Insider Transactions at Reneo Pharmaceuticals, Inc. (RPHM)
This section provides a real-time view of insider transactions for Reneo Pharmaceuticals, Inc. (RPHM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Reneo Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Reneo Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 14
2021
|
Wendy S. Johnson Chief Development Officer |
SELL
Open market or private sale
|
Direct |
111,736
-100.0%
|
$893,888
$8.5 P/Share
|
|
Jul 14
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
111,736
+5.11%
|
$893,888
$8.5 P/Share
|
|
Jul 08
2021
|
Wendy S. Johnson Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
111,736
+50.0%
|
$111,736
$1.97 P/Share
|
|
Jun 23
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
20,710
+1.04%
|
$186,390
$9.28 P/Share
|
|
Jun 22
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
14,615
+0.75%
|
$116,920
$8.72 P/Share
|
|
Jun 21
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
32,659
+1.67%
|
$293,931
$9.03 P/Share
|
|
Jun 08
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
16,605
+0.87%
|
$149,445
$9.5 P/Share
|
|
Jun 04
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
257
+0.01%
|
$2,313
$9.42 P/Share
|
|
Jun 03
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
12,100
+0.64%
|
$108,900
$9.25 P/Share
|
|
May 28
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
14
+0.0%
|
$126
$9.5 P/Share
|
|
May 27
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
1,120
+0.06%
|
$10,080
$9.26 P/Share
|
|
May 26
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
5,915
+0.32%
|
$53,235
$9.38 P/Share
|
|
Apr 13
2021
|
Michael G Grey |
BUY
Conversion of derivative security
|
Indirect |
20,162
+4.34%
|
-
|
|
Apr 13
2021
|
Bali Muralidhar Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+9.72%
|
$3,000,000
$15.0 P/Share
|
|
Apr 13
2021
|
Bali Muralidhar Director |
BUY
Conversion of derivative security
|
Indirect |
1,658,226
+50.0%
|
-
|
|
Apr 13
2021
|
Niall O'Donnell Director |
BUY
Open market or private purchase
|
Indirect |
200,000
+8.84%
|
$3,000,000
$15.0 P/Share
|
|
Apr 13
2021
|
Niall O'Donnell Director |
BUY
Conversion of derivative security
|
Indirect |
1,863,713
+40.39%
|
-
|
|
Apr 13
2021
|
New Enterprise Associates 15, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
666,666
+12.23%
|
$9,999,990
$15.0 P/Share
|
|
Apr 13
2021
|
New Enterprise Associates 15, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
4,118,828
+41.29%
|
-
|
|
Apr 13
2021
|
Novo Holdings > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
666,666
+16.27%
|
$9,999,990
$15.0 P/Share
|
|
Apr 13
2021
|
Novo Holdings > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,763,711
+50.0%
|
-
|
|
Apr 09
2021
|
River Vest Venture Fund Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
200,000
+7.67%
|
$3,000,000
$15.0 P/Share
|
|
Apr 09
2021
|
River Vest Venture Fund Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,929,878
+35.83%
|
-
|